Celldex Therapeutics (CLDX) PT Raised to $37 at Wells Fargo
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $41.70 -0.22%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Join SI Premium – FREE
Wells Fargo analyst Derek Archila raised the price target on Celldex Therapeutics (NASDAQ: CLDX) to $37.00 (from $35.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- JPMorgan Upgrades Nokian Renkaat Oyj (TYRES:FH) (NKRKY) to Neutral
- Morgan Advanced Materials plc (MGAM:LN) PT Raised to GBp2.35 at Deutsche Bank
- Hapag-Lloyd AG (HLAG:GR) (HPGLY) PT Raised to EUR117 at Deutsche Bank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
